These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

590 related articles for article (PubMed ID: 25746204)

  • 1. Nanostructured platforms for the sustained and local delivery of antibiotics in the treatment of osteomyelitis.
    Uskokovic V
    Crit Rev Ther Drug Carrier Syst; 2015; 32(1):1-59. PubMed ID: 25746204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro analysis of nanoparticulate hydroxyapatite/chitosan composites as potential drug delivery platforms for the sustained release of antibiotics in the treatment of osteomyelitis.
    Uskoković V; Desai TA
    J Pharm Sci; 2014 Feb; 103(2):567-79. PubMed ID: 24382825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in the local antibiotics delivery systems for management of osteomyelitis.
    Wassif RK; Elkayal M; Shamma RN; Elkheshen SA
    Drug Deliv; 2021 Dec; 28(1):2392-2414. PubMed ID: 34755579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An intramedullary nail coated with antibiotic and growth factor nanoparticles: An individualized state-of-the-art treatment for chronic osteomyelitis with bone defects.
    Berebichez-Fridman R; Montero-Olvera P; Gómez-García R; Berebichez-Fastlicht E
    Med Hypotheses; 2017 Aug; 105():63-68. PubMed ID: 28735655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticulate drug delivery platforms for advancing bone infection therapies.
    Uskoković V; Desai TA
    Expert Opin Drug Deliv; 2014 Dec; 11(12):1899-912. PubMed ID: 25109804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Early Results of Adjuvant Topical Treatment of Recurrent Osteomyelitis with Absorbable Antibiotic Carriers].
    Gramlich Y; Walter G; Gils J; Hoffmann R
    Z Orthop Unfall; 2017 Feb; 155(1):35-44. PubMed ID: 28081583
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutics and delivery vehicles for local treatment of osteomyelitis.
    Cobb LH; McCabe EM; Priddy LB
    J Orthop Res; 2020 Oct; 38(10):2091-2103. PubMed ID: 32285973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding osteomyelitis and its treatment through local drug delivery system.
    Nandi SK; Bandyopadhyay S; Das P; Samanta I; Mukherjee P; Roy S; Kundu B
    Biotechnol Adv; 2016 Dec; 34(8):1305-1317. PubMed ID: 27693717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase composition control of calcium phosphate nanoparticles for tunable drug delivery kinetics and treatment of osteomyelitis. II. Antibacterial and osteoblastic response.
    Uskoković V; Desai TA
    J Biomed Mater Res A; 2013 May; 101(5):1427-36. PubMed ID: 23115128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy with vancomycin-loaded calcium sulfate and vancomycin-loaded PMMA in the treatment of chronic osteomyelitis.
    Luo S; Jiang T; Yang Y; Yang X; Zhao J
    BMC Musculoskelet Disord; 2016 Dec; 17(1):502. PubMed ID: 28007027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Injectable borate glass/chitosan composite as drug carrier for treatment of chronic osteomyelitis].
    Zhao C; Wang X; Zhang C; Cui X; Jia W; Huang W
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2012 Jun; 26(6):641-6. PubMed ID: 22792754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apatite cement containing antibiotics: efficacy in treating experimental osteomyelitis.
    Sasaki S; Ishii Y
    J Orthop Sci; 1999; 4(5):361-9. PubMed ID: 10542040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodegradable vs non-biodegradable antibiotic delivery devices in the treatment of osteomyelitis.
    Kluin OS; van der Mei HC; Busscher HJ; Neut D
    Expert Opin Drug Deliv; 2013 Mar; 10(3):341-51. PubMed ID: 23289645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Injectable Chitosan-Based Thermosensitive Hydrogel/Nanoparticle-Loaded System for Local Delivery of Vancomycin in the Treatment of Osteomyelitis.
    Tao J; Zhang Y; Shen A; Yang Y; Diao L; Wang L; Cai D; Hu Y
    Int J Nanomedicine; 2020; 15():5855-5871. PubMed ID: 32848394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tricalcium phosphate, an antibiotic carrier: a study focused on experimental osteomyelitis in rabbits].
    Lambotte JC; Thomazeau H; Cathelineau G; Lancien G; Minet J; Langlais F
    Chirurgie; 1998 Dec; 123(6):572-9. PubMed ID: 9922597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase composition control of calcium phosphate nanoparticles for tunable drug delivery kinetics and treatment of osteomyelitis. I. Preparation and drug release.
    Uskoković V; Desai TA
    J Biomed Mater Res A; 2013 May; 101(5):1416-26. PubMed ID: 23115118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Bioglass-Based Antibiotic (Vancomycin) Releasing Bone Void Filling Putty to Treat Osteomyelitis and Aid Bone Healing.
    Hasan R; Schaner K; Mulinti P; Brooks A
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of nanomaterials to treat bone infections.
    Snoddy B; Jayasuriya AC
    Mater Sci Eng C Mater Biol Appl; 2016 Oct; 67():822-833. PubMed ID: 27287180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone infections and bone graft substitutes for local antibiotic therapy.
    Lalidou F; Kolios G; Drosos GI
    Surg Technol Int; 2014 Mar; 24():353-62. PubMed ID: 24504740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chitosan-based drug delivery systems: From synthesis strategy to osteomyelitis treatment - A review.
    Tao F; Ma S; Tao H; Jin L; Luo Y; Zheng J; Xiang W; Deng H
    Carbohydr Polym; 2021 Jan; 251():117063. PubMed ID: 33142615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.